PIM1 is a kinase that is overexpressed in prostate cancer, while the two isoforms, PIM-1S and PIM-1L, are the major mediators of AR serine 213 (Ser-213) and threonine 850 (Thr-850) phosphorylation. Here, PIM1 is linked to prostate carcinoma.